Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical GW870086X in Moderate to Severe Atopic Dermatitis
NCT01299610Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2010
- Primary completion
- Mar 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of GW870086 in atopic dermatitis (AD), sponsored by GSK. Started Dec 2010; status: completed.
02
Drugs
GW870086
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01299610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01299610.